Global Presence Sun Pharmaceuticals has a strong global presence, with operations in over 200 countries, supported by 40 manufacturing facilities and a diverse workforce from over 50 nationalities. This extensive reach provides ample sales opportunities in multiple markets.

Cutting-Edge R&D With around 2000 research scientists and advanced R&D centers equipped with cutting-edge technologies, Sun Pharma invests significantly in research and development. Leveraging their innovative capabilities can open doors to selling new, groundbreaking pharmaceutical products.

Industry Leadership Sun Pharmaceuticals ranks among top competitors like Cipla, Dr. Reddy's Laboratories, and Teva Pharmaceuticals in terms of revenue and employee size. Establishing strategic partnerships or competitive pricing can help capitalize on Sun Pharma's position in the industry.

Diverse Product Portfolio With a focus on manufacturing and selling pharmaceutical formulations and APIs, Sun Pharma offers a diverse product portfolio. Leveraging the variety of products can generate cross-selling or upselling opportunities to existing and potential clients.

Financial Stability Despite the funding amount not specified, Sun Pharmaceuticals' revenue is in the range of $1 billion. This suggests financial stability that can be attractive to potential buyers or investors seeking reliable pharmaceutical partners.